✦ LIBER ✦

Donor Cell-Derived Chronic Myeloproliferative Disease with t(7;11)(p15;p15) after Cord Blood Transplantation in a Patient with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

✍ Scribed by Hideki Mitsui; Tsuyoshi Nakazawa; Akira Tanimura; Takahiro Karasuno; Akira Hiraoka

Book ID: 111835641
Publisher: Carden Jennings Publishing
Year: 2007
Tongue: English
Weight: 172 KB
Volume: 86
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.06162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Donor cell derived acute myeloid leukemi

Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma

✍ Takuya Matsunaga; Kazuyuki Murase; Makoto Yoshida; Akihito Fujimi; Satoshi Iyama 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 3 views

Successful Eradication of Residualbcr-ab

Successful Eradication of Residualbcr-abl-Positive Clones by Donor Leukocyte Transfusion in a Patient With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia After Peripheral Blood Stem Cell Transplantation

✍ Takayuki Tabayashi; Kohzou Masuda; Konagi Yamada; Masami Takeuchi; Kosei Matsue 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 65 KB

Inv (11)(p15q21) in donor-derived Ph-neg

Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation

✍ Bruno C. Medeiros; Kathy Chun; Suzanne Kamel-Reid; Jeffrey Lipton 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract Imatinib mesylate (IM) is the standard first‐line treatment for patients with chronic myeloid leukemia (CML). Surprisingly, 2–15% of patients achieving a complete cytogenetic response develop cytogenetic abnormalities in Philadelphia (Ph)‐negative cells. Following hematopoietic stem cel